Case 1:21-cv-01066-T JM-CFH Document 189 Filed 10/18/21 Pag
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF NEW YORK
`
`[lrof1~ R1cr couRr - No oF NY
`FILED
`
`Oct 18 - 2021
`
`John M. Domurad, Clerk
`
`REGENERON PHARMACEUTICALS, INC.,
`
`Civil Action No. 1 :21-cv-01066-TJM
`
`Plaintiff,
`
`The Honorable Judge Thomas J. McA voy
`
`• VS•
`
`NOVARTIS PHARMA AG, et. al,
`
`Defendants.
`
`~ ORDER GRANTING UNOPPOSED MOTION FOR APPOINTMENT OF
`COMMISSIONERS AND DIRECTION OF SUBMISSION OF HAGUE CONVENTION
`APPLICATION
`
`On October 14, 2021, Defendants Novartis Pharma AG, Novartis Pharmaceuticals
`
`Corporation, and Novartis Technology LLC (collectively, ''Novartis") filed an unopposed motion
`
`seeking entry of an order appointing certain U.S. attorneys as commissioners to take the
`
`voluntary oral depositions under oath via video conference in Switzerland of certain Novartis
`
`witnesses (the "Motion"). Dkt. 183.
`
`Novartis seeks authorization from a competent Swiss authority to conduct voluntary
`
`depositions under oath via videoconference of seven witnesses, whom Regeneron
`
`Pharmaceuticals, Inc. ("Regeneron") seeks to depose, and who either live or work in
`
`Switzerland. The Swiss Penal Code provides that attorneys attempting to take a deposition or
`
`carry out other activities on behalf of a foreign state in Switzerland outside of authorized methods
`
`are subject to arrest on criminal charges. Id at 2-3 (citing Article 271 of the Swiss Penal Code).
`
`Thus, Novartis represents it must comply with the Hague Convention in seeking testimony in
`
`this investigation in order to comply with Swiss law. See id. at 3.
`
`I find that the evidence the parties seek is reasonably necessary to fully investigate
`
`WEIL:\98209068\1169396.0009
`
`Novartis Exhibit 2331.0001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF NEW YORK
`
`[lrof1~ R1cr couRr - No oF NY
`FILED
`
`Oct 18 - 2021
`
`John M. Domurad, Clerk
`
`REGENERON PHARMACEUTICALS, INC.,
`
`Civil Action No. 1 :21-cv-01066-TJM
`
`Plaintiff,
`
`The Honorable Judge Thomas J. McA voy
`
`• VS•
`
`NOVARTIS PHARMA AG, et. al,
`
`Defendants.
`
`~ ORDER GRANTING UNOPPOSED MOTION FOR APPOINTMENT OF
`COMMISSIONERS AND DIRECTION OF SUBMISSION OF HAGUE CONVENTION
`APPLICATION
`
`On October 14, 2021, Defendants Novartis Pharma AG, Novartis Pharmaceuticals
`
`Corporation, and Novartis Technology LLC (collectively, ''Novartis") filed an unopposed motion
`
`seeking entry of an order appointing certain U.S. attorneys as commissioners to take the
`
`voluntary oral depositions under oath via video conference in Switzerland of certain Novartis
`
`witnesses (the "Motion"). Dkt. 183.
`
`Novartis seeks authorization from a competent Swiss authority to conduct voluntary
`
`depositions under oath via videoconference of seven witnesses, whom Regeneron
`
`Pharmaceuticals, Inc. ("Regeneron") seeks to depose, and who either live or work in
`
`Switzerland. The Swiss Penal Code provides that attorneys attempting to take a deposition or
`
`carry out other activities on behalf of a foreign state in Switzerland outside of authorized methods
`
`are subject to arrest on criminal charges. Id at 2-3 (citing Article 271 of the Swiss Penal Code).
`
`Thus, Novartis represents it must comply with the Hague Convention in seeking testimony in
`
`this investigation in order to comply with Swiss law. See id. at 3.
`
`I find that the evidence the parties seek is reasonably necessary to fully investigate
`
`WEIL:\98209068\1169396.0009
`
`Novartis Exhibit 2331.0001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Case 1:21-cv-01066-TJM-CFH Document 189 Filed 10/18/21 Page 2 of 4
`
`Novartis's claims of patent infringement and Regeneron's antitrust and tortious interference
`
`claims in this litigation. I also find that the evidence Novartis and Regeneron seek is reasonably
`
`necessary to fully investigate the parties' claims and defenses in this litigation. Accordingly, the
`
`Motion is granted.
`
`The following listed counsel for Novartis, Vetter, and Regeneron are duly appointed as
`
`commissioners under Article 17 of the Hague Convention of 17 March 1970 on the Taking of
`
`Evidence Abroad in Civil or Commercial Matters:
`
`Counsel at Weil, Gotshal & Manges LLP (located at 767 Fifth
`
`Avenue New York, New York 10153; and 2001 M Street, Suite 600
`
`Washington, DC 20036) for PlaintiffRegeneron (Regeneron
`
`Pharmaceuticals, Inc., located at 777 Old Saw Mill River Road,
`
`Tarrytown, New York 10591, USA): Anish Desai; Elizabeth
`
`Weiswasser; Eric Hochstadt; Jessica Falk; Liz Klinger; Brian
`
`Ferguson; Robert Vlasis; Christopher Pepe; Sutton Ansley;Priyata
`
`Patel; Natalie Kennedy; Matthew Sieger; Andrew Gesior; Brianne
`
`Kucerik; Lisa Pieters; Anthony Duh; John Ren; Isha Agarwal; and
`
`Tom Yu;
`
`Counsel at Barclay Damon LLP (located at Barclay Damon
`
`Tower, 125 East Jefferson Street Syracuse, NY 13202) for Plaintiff
`
`Regeneron (Regeneron Pharmaceuticals, Inc., located at 777 Old Saw
`
`Mill River Road, Tarrytown, New York 10591, USA): John Cook and
`
`Douglas Nash;
`
`Counsel at Goodwin Procter LLP (located at The New York
`
`Times Building 620 Eighth Avenue New York, NY 10018-1405; and
`
`1900 N Street, N.W. Washington, D.C. 20036-1612) for Defendant
`
`Novartis (Novartis Pharma AG, Forum 1, Novartis Campus, 4056
`
`Basel, Switzerland; Novartis Pharmaceuticals Corporation, One Health
`
`Plaza, East Hanover, New Jersey, 07936, USA and Novartis
`
`Technology LLC, One Health Plaza, East Hanover, New Jersey, 07936,
`
`WEIL:\98209068\1\69396.0009
`
`Novartis Exhibit 2331.0002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Case 1:21-cv-01066-TJM-CFH Document 189 Filed 10/18/21 Page 3 of 4
`
`USA): Sean Anderson; James Breen; Brian Burgess; Linnea
`
`Cipriano; Myomi Coad; Nicole Corey; Tova Dardashty; Mark
`
`Davis; Gina Faldetta; Denise Go; Molly Grammel; Christopher
`
`Holding; Elizabeth Holland; William James; Daniel Margolis; Patrick
`
`McCarthy; Christine Sama; Alison Siedor; Grace Truong; Joshua
`
`Weinger; and Calvin Wingfield;
`
`Counsel at O'Melveny & Myers LLP (located at Times Square
`
`Tower, 7 Times Square New York, New York 10036; 1625 Eye Street
`
`NW Washington, DC 20006; and 400 South Hope Street, 18th Floor,
`
`Los Angeles, California 90071-2899) for Defendant Novartis
`
`(Novartis Pharma AG, Forum 1, Novartis Campus, 4056 Basel,
`
`Switzerland; Novartis Pharmaceuticals Corporation, One Health Plaza,
`
`East Hanover, New Jersey, 07936, USA and Novartis Technology
`
`LLC, One Health Plaza, East Hanover, New Jersey, 07936, USA):
`
`George Bashour; Ben Bradshaw; Melissa Cassel; Maxwell Loos; Tyler
`
`Helms; Christina Martin; Steve McIntyre; Lisa Pensabene; Ian
`
`Simmons; Ashish Sudhakaran; and Sean Trainor;
`
`Counsel at Bond Schoeneck & King, PLLC (located at One
`
`Lincoln Center, Syracuse, NY 13202) for Defendant Novartis
`
`(Novartis Pharma AG, Forum 1, Novartis Campus, 4056 Basel,
`
`Switzerland; Novartis Pharmaceuticals Corporation, One Health Plaza,
`
`East Hanover, New Jersey, 07936, USA and Novartis Technology
`
`LLC, One Health Plaza, East Hanover, New Jersey, 07936, USA):
`
`George McGuire and Louis Orbach;
`
`Counsel at Bar & Karrer AG (located at Brandschenkestrasse
`
`90, 8027 Zurich, Switzerland) for Defendant Novartis (Novartis
`
`Pharma AG, Forum 1, Novartis Campus, 4056 Basel, Switzerland;
`
`Novartis Pharmaceuticals Corporation, One Health Plaza, East
`
`Hanover, New Jersey, 07936, USA and Novartis Technology LLC, One
`
`Health Plaza, East Hanover, New Jersey, 07936, USA): Dr. Andreas
`
`WEIL:\98209068\1\69396.0009
`
`Novartis Exhibit 2331.0003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Case 1:21-cv-01066-TJM-CFH Document 189 Filed 10/18/21 Page 4 of 4
`
`Lanzlinger; and Martina Athanas; and
`
`Counsel at Marshall, Gerstein & Borun LLP (located at 233
`
`South Wacker Drive, 6300 Willis Tower Chicago, IL 60606-6357), for
`
`Defendant Vetter (Vetter Phanna International GmbH, Mooswiesen 2,
`
`88214 Ravensburg, Germany): Benjamin Horton, Julianne Hartzell,
`
`and Thomas Bums.
`
`This Order shall be given to counsel at Bar & Karrer AG who will file it together with
`
`the necessary application for authorization from the relevant Swiss authorities.
`
`ORDER
`
`Based on the Motion, IT IS SO ORDERED this 18th day of October
`
`, 2021.
`
`C/4..ulJ•· r t~
`
`Christian F. Hummel
`U.S. Magistrate Judge
`
`WEIL:\98209068\1169396.0009
`
`Novartis Exhibit 2331.0004
`Regeneron v. Novartis, IPR2021-00816
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
